ambossIconambossIcon

Immunization schedule

Last updated: January 14, 2025

Summarytoggle arrow icon

Vaccinations are one of the most effective methods of disease prevention, drastically reducing illness, hospitalizations, and deaths from infectious diseases. In order to prevent a resurgence of vaccine-preventable illnesses in the US, the Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) publish yearly immunization schedule recommendations. These schedules are formulated based on extensive research and aim to protect individuals at the age at which they have the highest risk for infection. Specific recommendations are available for the general population (children and adults), individuals with certain health conditions, and those traveling to areas with high rates of infection. Education on the importance of vaccination and the implementation of catch-up schedules for underimmunized individuals are vital to ensuring herd immunity and preventing infectious diseases.

Icon of a lock

Register or log in , in order to read the full article.

General principlestoggle arrow icon

Routine immunization [1][2][3]

Vaccine dose is not adjusted for weight but may vary based on age.

It is US federal law to provide a Vaccine Information Statement before the administration of every vaccine. [5]

Vaccinations against multiple diseases at the same visit [3]

Simultaneous vaccination

Administration of > 1 vaccine on the same day, but in different syringes and at different anatomical locations

If injectable or nasally administered live vaccines are not administered on the same day, they must be administered ≥ 4 weeks apart. [3]

Live oral vaccines (e.g., rotavirus vaccine) may be administered on the same day or at any interval before or after other live vaccines. [3]

Combination vaccines [3]

Combination of different vaccine components in a single product

  • Preferred over simultaneous single-component vaccines, when feasible
  • Examples of commonly used combination vaccines:
    • DTaP-IPV-Hib
    • DTaP-HepB-IPV
    • DTaP-IPV-HepB-Hib
    • DTaP-IPV
    • MMRV [7]
    • HepA-HepB

Timing and spacing of vaccines [3]

  • Follow the ACIP recommendations for the minimum age for the first dose and minimum intervals between doses to ensure optimal protection.
  • Unapproved delayed or alternate immunization schedules put individuals at risk.

Delayed or missed vaccines (undervaccination) [1][2]

Vaccines administered before the recommended minimum age or interval [3]

In general, any vaccine administered ≥ 5 days earlier than the minimum age or interval is considered invalid and needs to be repeated.

  • First dose administered ≥ 5 days earlier than the recommended minimum age
    • Repeat the dose when or after the individual attains the minimum recommended age.
    • For live vaccines, repeat the first dose ≥ 28 days after the invalid first dose.
  • Additional doses administered ≥ 5 days earlier than the recommended minimum interval
    • Repeat the dose; the minimum interval restarts from when the invalid dose was administered.

Doses administered ≤ 4 days before the minimum age or interval (grace period) are considered valid. [3]

Icon of a lock

Register or log in , in order to read the full article.

ACIP immunization scheduletoggle arrow icon

This table provides an overview of the ACIP immunization schedule. See the latest CDC recommendations for detailed guidance.

Any mention of vaccine trade names is only for the purposes of identification and should not be considered an endorsement.

For catch-up vaccines, continue with the next dose in the immunization series. Do not restart the immunization series from the beginning. [2]

Overview of ACIP immunization schedule [1][2]

Routine immunization schedule

Catch-up immunization schedule and immunization schedule by medical indication

Special considerations

Respiratory syncytial virus prophylaxis and vaccination

RSV prophylaxis (children) [8][9]

  • Rarely, nirsevimab may be considered for infants of vaccinated mothers based on clinical judgment.
RSV vaccine (adults) [11]
  • Young children, pregnant individuals, and older adults are at increased risk of severe RSV infection.
  • Immunization can occur at any time; late summer or early fall is ideal.

Hepatitis B vaccine
(HepB)

Tetanus, diphtheria, and acellular pertussis vaccines

Diphtheria, tetanus, acellular pertussis vaccine
(DTaP)

  • DTaP primary series: 3 doses
    • Dose 1: 2 months of age
    • Dose 2: 4 months of age
    • Dose 3: 6 months of age
  • Boosters
    • Dose 4: 15–18 months of age
    • Dose 5: 4–6 years of age
    • Proceed to Tdap boosters after 11–12 years of age.
  • If < 7 years of age: 4–5 doses total of DTaP [2]
  • If ≥ 7 years of age: See catch-up schedule for Tdap. [2]
Tetanus, diphtheria, acellular pertussis vaccine (Tdap)
and tetanus, diphtheria vaccine (Td)
  • Individuals ≥ 7 years of age with:
    • Incomplete DTaP series: 1 dose of Tdap; followed by either Tdap OR Td for subsequent doses as needed. [12]
    • Completed DTaP series (with incomplete Tdap): 1 dose of Tdap; then Tdap OR Td boosters every 10 years [12]
Inactivated poliovirus vaccine (IPV)
  • IPV primary series: 3 doses
    • Dose 1: 2 months of age
    • Dose 2: 4 months of age
    • Dose 3: 6–18 months of age
  • Booster: Dose 4 at 4–6 years of age
Rotavirus vaccine (RV)
  • RV primary series: 2 or 3 doses (varies by vaccine)
    • Dose 1: 2 months of age
    • Dose 2: 4 months of age
    • Dose 3 (for the 3-dose vaccine only): 6 months of age
  • Age < 8 months: 1–3 doses total(depending on age and vaccine)
  • Minimum age for the first dose: 6 weeks
  • Maximum age for the first dose: 14 weeks 6 days
  • Maximum age for final dose: 8 months
Haemophilus influenzae type b vaccine (Hib vaccine)
  • Hib primary series: 2 or 3 doses (varies by vaccine)
    • Dose 1: 2 months of age
    • Dose 2: 4 months of age
    • Dose 3: 6 months of age (for all series except PedvaxHIB)
  • Booster: Dose 4 at 12–15 months of age
  • Minimum age for the first dose: 6 weeks

Pneumococcal vaccines
See “Tips and Links” for CDC's mobile app for pneumococcal vaccines.

Children (PCV15, PCV20) [13][14]
  • PCV primary series: 3 doses (PCV15 or PCV20)
    • Dose 1: 2 months of age
    • Dose 2: 4 months of age
    • Dose 3: 6 months of age
  • Booster (PCV15 or PCV20): Dose 4 at 12–15 months of age

Adults (PCV15, PCV20, PCV21, PPSV23) [15][16]

Hepatitis A vaccine (HepA)
  • All children: 2 doses, given:
    • Between 12 and 23 months of age
    • AND ≥ 6 months apart
Measles, mumps, rubella vaccine (MMR)
or
Measles, mumps, rubella, varicella vaccine (MMRV)
  • All children: 2 doses
    • Dose 1: 12–15 months of age (MMR preferred over MMRV) [17]
    • Dose 2: 4–6 years of age
Varicella vaccine (VAR)
  • All children: 2 doses
    • Dose 1: 12–15 months of age (VAR preferred over MMRV)
    • Dose 2: 4–6 years of age
Human papillomavirus 9-valent vaccine (HPV vaccine)
  • All children (male and female): 2 doses
    • Dose 1: between 11 and 12 years of age
    • Dose 2: 6–12 months after dose 1
  • Individuals ≤ 26 years of age: Catch-up is recommended; dosage depends on age at initial vaccination.
    • 9–14 years of age at initial dose: 2-dose series
    • ≥ 15 years of age at initial dose: 3-dose series at 0, 1–2 months, and 6 months
  • Adults 27–45 years of age: Use shared decision-making.
  • Immunocompromised individuals: Use a 3-dose series regardless of age at first dose.
  • Minimum age for the first dose: 9 years
  • Individuals with a complete HPV vaccine series of any valency do not need additional doses.
  • History of sexual abuse: Start 2-dose series at 9 years of age.

Meningococcal vaccines [19]

Meningococcal conjugate vaccines (MenACWY vaccines)
  • All children: 2 doses
    • Dose 1: 11–12 years of age
    • Dose 2: 16 years of age
  • 13–15 years of age: 2 doses total
    • Dose 1: as soon as possible
    • Dose 2: at 16–18 years of age; ≥ 8 weeks after dose 1
  • 16–18 years of age : 1 dose total
  • Individuals ≥ 2 months with risk factors for invasive meningococcal disease [19][20]
    • Primary series: 2–4 doses (differs by age and vaccine) See the latest CDC recommendations.
    • Ongoing risk: booster doses [19]
      • Age < 7 years: booster dose 3 years after primary series; then every 5 years
      • Age ≥ 7 years: booster dose every 5 years
  • Minimum age for first dose: differs by vaccine and formulation
  • MenACWY vaccines are interchangeable. [19]
  • MenB vaccines are not interchangeable.
  • If both MenACWY and MenB are indicated, they may be coadministered with either
    • Simultaneous MenACWY and MenB at different anatomical sites
    • Pentavalent meningococcal vaccine (MenACWY-TT/MenB-FHbP) in individuals 10–25 years of age [21]
Meningococcal B vaccine (MenB vaccine)
Zoster recombinant vaccine (RZV)
  • Adults > 50 years of age: 2 doses, 2–6 months apart
  • Individuals ≥ 19 years of age with current or anticipated immunocompromise : 2 doses, 2–6 months apart [22]
  • Minimum age for the first dose: 19 years
Influenza vaccine [23][24]
  • All individuals ≥ 6 months of age: 1 dose annually just before or during flu season
  • Children aged 6 months–8 years who received ≤ 1 dose of any influenza vaccine before July 1, 2024: Administer 2 doses, ≥ 4 weeks apart. [23]

Covid-19 vaccines [25][26]

Children 6 months to < 5 years of age
Children ≥ 5 years of age and adults

Mpox vaccine[29]

  • N/a
Dengue vaccine [30]
  • N/a
  • Children 9–16 years of age who:
  • 3-dose series: 0, 6, and 12 months

Unapproved delayed or alternate immunization schedules put individuals at risk for vaccine-preventable conditions and complications. [3]

Egg allergy is not a contraindication for any influenza vaccination. [23]

Icon of a lock

Register or log in , in order to read the full article.

Immunizations at each health maintenance or well-visit encountertoggle arrow icon

The youngest recommended age for routine immunization is shown in this table. Refer to the ACIP immunization schedule for details on age ranges, catch-up immunizations, and special considerations.

For individuals ≥ 6 months of age, recommend age-appropriate COVID-19 vaccination and yearly influenza vaccination during influenza season.

The use of combination vaccines can decrease the number of injections needed at each encounter. Combination vaccines are frequently used for the 2-month, 4-month, 6-month, and 4–6-year immunizations. They may also be used for catch-up immunizations.

Immunizations at each health maintenance or well-visit encounter [1][2]
Newborn follow-up at 2 weeks

2 months

4 months
6 months
9 months
12 months
15 months
  • Booster dose of of DTaP (4th dose)

18 months

24, 30, and 36 months

4–6 years

6–10 years

11 years

12–15 years
16 years
17 years
Immunizations in adults All adults
Additional immunizations in adults ≥ 50 years of age

Icon of a lock

Register or log in , in order to read the full article.

Special patient groupstoggle arrow icon

Immunizations in individuals with HIV [1][2][33]

Exceptions to the routine immunization schedule

The routine ACIP immunization schedule is applicable to individuals with HIV with the following exceptions:

Live vaccines are contraindicated if CD4 count is < 200 cells/mm3 or CD4 percentage is < 15%. [1][2]

The efficacy of immunizations is reduced in individuals with HIV as a result of impaired immune function. [35]

Immunizations in preterm infants [36]

Immunizations in pregnancy and lactation [1][37][38][39]

Prior to pregnancy [37][40]

During pregnancy [1][37][38]

MMR vaccine, varicella vaccine, HPV vaccine, and live attenuated influenza vaccine are not recommended during pregnancy. [1][2]

After pregnancy and/or during lactation [37]

Lactation is not a contraindication for most vaccines.

Women who lack immunity to rubella and/or varicella on prenatal screening (see “Prenatal care”) should be vaccinated postpartum.

Always consider if the benefits of immunization outweigh the risks during pregnancy and lactation; check contraindications. [40]

Immunizations for health care personnel (HCP) [48][49]

The following immunizations are an essential part of minimizing the risk of occupational exposure to and transmission of vaccine-preventable diseases in HCP.

Vaccine recommendations for all HCP [49][50]

Additional vaccines in high-risk groups [48][50]

Verify immunization requirements with the local occupational health department.

Immunizations in men who have sex with men [1][51][52]

Icon of a lock

Register or log in , in order to read the full article.

Immunizations before traveltoggle arrow icon

Approach [54]

Immunizations are not effective immediately, and certain malaria prophylaxis must be initiated 1–2 weeks before traveling to high-risk areas. [54][56]

Overview of additional immunizations before travel

This table provides an overview of the pretravel immunizations recommended for individuals from the United States who are planning international travel.

Overview of travel immunizations [54]
Immunization Schedule Minimum age Risk areas Recommendation Other considerations

Meningococcal conjugate vaccine [19][57][58]

  • 2 months–2 years of age: 2 or 4 doses (depending on age and vaccine)
  • ≥ 2 years of age: 1 dose
  • Give ≥ 10 days before traveling.
  • Booster doses every 3–5 years for future travel or if ongoing exposure or reexposure is expected
  • Recommended for individuals traveling to or residing in hyperendemic or epidemic countries who are in close contact with local residents

Typhoid and paratyphoid fever vaccine [59]

  • Inactivated typhoid vaccine (injection): 1 dose
    • Give ≥ 2 weeks before traveling.
    • Booster dose every 2 years
  • Live typhoid vaccine (oral): 4 doses (48 hours between each dose)
    • Give ≥ 10 days before traveling.
    • Booster dose every 5 years
  • Recommended for travelers to most countries
  • Recommended for travelers who may consume potentially contaminated food and beverages
  • Recommended for those staying in rural areas and/or small cities
  • Prevents illness in 50–80% of individuals [59]
Japanese encephalitis vaccine [60]
  • 2 doses, 28 days apart
  • Should be completed ≥ 1 week before travel
  • 1 booster dose ≥ 1 year after dose 2 if ongoing exposure or reexposure is expected
  • 2 months
  • Southeast Asia and the Western Pacific
  • Countries with outbreaks of Japanese encephalitis
  • Endemic areas include rural agricultural areas.
  • In temperate areas, there are seasonal peaks in summer and fall.
  • In the subtropics and tropics, transmission occurs year-round; peaks in the rainy season.
  • Recommended for long-term (≥ 1 month) and frequent travelers to endemic regions
  • Should be considered for short-term travelers to endemic regions

Yellow fever vaccine [61]

  • 1 dose; given ≥ 10 days before departure.
  • A booster dose is recommended in the following situations:
  • 9 months
  • Africa, South America, and parts of Panama
  • Recommended for all travelers visiting or residing in areas with increased risk
  • Many African and South American countries require proof of vaccination from incoming travelers.
  • One dose provides lifelong protection; a booster dose may be required certain high-risk groups.
  • Recommend mosquito bite prevention.

Rabies vaccine [62][63]

  • 2 doses, 7 days apart
  • The series should be completed before travel.
  • Titer levels and booster doses may be needed. [63]
  • None
  • Rabies has been found on all continents except Antarctica.
  • Considered for:
    • Individuals traveling to rural areas
    • Individuals with risk factors
Inactivated poliovirus vaccine (IPV) [64]
  • Adults and children with an incomplete primary series: Complete primary IPV series before travel.
  • Adults with a complete primary series: Give a one-time booster dose.
  • 6 weeks
  • Middle East, Africa [65]
  • Recommended for all travelers to endemic regions
  • Accelerated dosing schedules are recommended for those who cannot complete the standard primary IPV series before travel.
  • See the latest CDC recommendations for further guidance.
Chikungunya vaccine [66]
  • 1 dose
  • 18 years
  • Certain countries in Africa, Asia, and South America
  • Recommended for travelers to areas with an outbreak
  • Consider in those with the following risk factors if traveling to areas with chikungunya virus transmission in the past 5 years [66]
    • Stays ≥ 6 months
    • Age > 65 years and likely to have ≥ 2 weeks of cumulative mosquito exposure
Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer